- Prof. Anderson’s interview with the IJS
January 9, 2013
Listen to Prof. Craig Anderson’s interview with the IJS on the upcoming publication of the INTERACT2 Statistical Analysis Plan (SAP). Continue reading
- Final Issue of the INTERACT2 Informer
November 5, 2012
Farewell from INTERACT2 Informer. In this final issue, read about our final recruitment numbers, our plans for announcing the results and also some handy tips for sites that are in the process of closing out. Continue reading
- UK reaches their recruitment target!
August 31, 2012
Congratulations to the UK for reaching their regional recruitment target of 70 patients! Continue reading
The second (main phase) of the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial or INTERACT2, is the largest ever clinical trial in acute intracerebral haemorrhage (ICH). At the end of the study, 2800 patients will have participated from nearly 140 hospital sites around the world. The study will answer an important clinical question of whether early and intensive lowering of high blood pressure after an ICH will improve the chances of a patient surviving free of major disabilty.
In this website, you will be able to find information on the study, recruitment updates, download our newsletters, and read about the latest news and results. If you are a Health Professional, please navigate to the Health Professional section to find information appropriate for your needs.
For more information on stroke, visit your national Stroke Foundation or Association website.
For Australia, please visit http://www.strokefoundation.com.au/